Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 37 of 37 entries
View as:

Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT01617239 Org: User:
Start: 06/30/12 End: 12/31/13 Due: 12/31/14

A Study to Assess the Immunogenicity, Tolerability and Safety of a Malaria Vaccine and Also Its Protective Efficacy in a Malaria Challenge Model

Phase: N/A Priority: Normal
NCT ID: NCT01397227 Org: User:
Start: 06/30/11 End: 05/31/12 Due: 05/31/13

A Study to Assess Immunogenicity Parameters After Vaccination Against Influenza and to Evaluate How These Parameters Change During the Influenza Season

Phase: N/A Priority: Normal
NCT ID: NCT01457027 Org: User:
Start: 10/31/11 End: 08/31/12 Due: 08/31/13

Immunogenicity and Safety of a Single 0.5 mL Dose of Inflexal V With a 0.25 mL 2-dose Regimen of Inflexal V

Phase: N/A Priority: Normal
NCT ID: NCT01229397 Org: User:
Start: 10/31/10 End: 11/30/10 Due: 11/30/11

Randomized Phase II Trial on Safety and Neutralizing Activity of CL184 and Rabies Vaccine Versus Human Rabies Immune Globulin (HRIG) and Rabies Vaccine in Children and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT00708084 Org: User:
Start: 05/31/08 End: 10/31/08 Due: 10/31/09

Safety, Tolerability and Immunogenicity Study of 2 Dose Levels of Trimeric Glycoprotein140 (gp140) in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02304185 Org: User:
Start: 12/31/14 End: 04/30/16 Due: 04/30/17

A Phase I Study of an HIV Vaccine in Healthy, HIV Uninfected Adults

Phase: N/A Priority: Normal
NCT ID: NCT02218125 Org: User:
Start: 09/23/14 End: 11/30/15 Due: 11/30/16

A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2010/2011 Influenza Virus Strains for the Northern Hemisphere

Phase: N/A Priority: Normal
NCT ID: NCT01306305 Org: User:
Start: 06/30/10 End: 07/31/10 Due: 07/31/11

Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Different Suppliers

Phase: N/A Priority: Normal
NCT ID: NCT01412281 Org: User:
Start: 10/31/11 End: 12/31/11 Due: 12/31/12

A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject

Phase: N/A Priority: Normal
NCT ID: NCT01917357 Org: User:
Start: 09/30/13 End: 04/30/14 Due: 04/30/15

Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Suppliers

Phase: N/A Priority: Normal
NCT ID: NCT01229371 Org: User:
Start: 10/31/10 End: 12/31/10 Due: 12/31/11

Long Term Follow-up of a Study to Assess the Safety and Immunogenicity of a Hepatitis A Vaccine Administered With and in the Absence of DTPaHibIPV, OPV and MMR Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT01307436 Org: User:
Start: 03/14/07 End: 07/08/13 Due: 07/08/14